Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

Introduction Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs).Materials and methods We retrospectively analysed the clinical features, treatment response, and long-term outcomes of...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2022-12-01
Colección:	Annals of Medicine
Materias:	Chronic phase chronic myeloid leukaemia adolescents and young adults tyrosine kinase inhibitors Dasatinib Nilotinib
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/07853890.2022.2069280
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!